REGULATORY COMPLIANCE
-
Pharma Industry Needs Precise FDA Guidelines for AI, ML, and RPA Validation : Experts
Experts at the second edition of Next-Gen LabCon discussed the capabilities of artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA) in enhancing research and development (R&D) processes. The panel experts underscored the transformative potential of AI, ML, and RPA in pharmaceutical R&D while highlighting the critical need for human expertise and robust regulatory frameworks.
-
Partnerships as catalysts: The role of collaborations in advancing pharmaceutical innovation
-
Digital Solutions an enabler in regulatory compliance inform pharma experts
-
Export-focused pharma cos need to improve compliance: Report
-
Pharma industry backs government's decision to defer trade talks with European Union
Join the community of 2M+ industry professionals
Subscribe to our Daily Newsletter
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
